Jesus Berdeja

No bio available.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Genentech
    Topic: 
    Clinical Research Support
    Date added: 
    02/28/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    GSK
    Topic: 
    Clinical Research Support
    Date added: 
    02/28/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Ichnos Sciences
    Topic: 
    Clinical Research Support
    Date added: 
    02/28/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Incyte
    Topic: 
    Clinical Research Support
    Date added: 
    02/28/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Janssen
    Topic: 
    Clinical Research Support
    Date added: 
    02/28/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Karyopharm
    Topic: 
    Clinical Research Support
    Date added: 
    02/28/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Sanofi
    Topic: 
    Clinical Research Support
    Date added: 
    02/28/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Takeda
    Topic: 
    Clinical Research Support
    Date added: 
    02/28/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Zentalis
    Topic: 
    Clinical Research Support
    Date added: 
    02/28/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Bluebird
    Topic: 
    Consultant
    Date added: 
    02/28/2023

Pages

Return to 2023 Annual Summit on Hematologic Cancers: Incorporation of Novel Therapies in Clinical Practice